OClawVPS.com
Edit

OneVentures

https://www.one-ventures.com.au/
Last activity: 14.01.2025
Active
Invests in categories: PlatformLearnTechnologyLegalTechEdTechOnlineE-commerceServiceSoftwareManagement
We are one of Australia’s leading venture capital firms, with almost $400 million in funds under management. But we do more than invest. We work with companies to take them to that all important next stage, by actively shaping their future.
Portfolio
40
Persons
24
Mentions
29
Employees: 11-50
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B; Series D
.

Portfolio 40

DateNameWebsiteTotal RaisedLocation
29.07.2023LegalVisio...legalvision.com.au$4.2MAustralia,...
29.07.2023Kepler Ana...kepleranalytics.com-Australia,...
29.07.2023ImmVirXimmvirx.com-Australia,...
29.07.2023XY Sensexysense.com$10MUnited Kin...
29.07.2023Buildkitebuildkite.com$60MAustralia,...
29.07.2023AmazingCoamazingco.me-Australia,...
29.07.2023Drawboarddrawboard.com-Australia,...
11.07.2022Fleet Spac...fleetspace.com--
31.10.2019Kirakirabiotech.com$20MAustralia,...
29.06.2016Employment...employmenthero.com$514.8MAustralia,...
Show more

Persons 24

DateFirst NameLast NameTitleLinkedInLocation
-HeatherMaini--
-JustineCarzinoInvestment...linkedin.c...-
-NigelDewsOperating ...linkedin.c...-
-JustinLaiFinancial ...linkedin.c...-
-DrMichelle D...-linkedin.c...-
-JillAllen-linkedin.c...-
-LennyZeng--
-MariaBaas-linkedin.c...-
-DrDan BakerVenture Pa...linkedin.c...-
-RhiannaMiller-linkedin.c...-
Show more

Mentions in press and media 29

DateTitleDescription
14.01.2025Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for VaccinationJanuary xx, 2025 – BRISBANE, Australia & CAMBRIDGE, Mass. – Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, has been named a Concept Stage Winner of the...
23.10.2023No VC funding? Seven alternative ways to fund your startup in Australiaarticle-article-body I was at a startup event last month which included a panel session involving a number of Australia’s leading Venture Capital firms. The room featured a range of startups and scale-ups who were keen for insights on how t...
23.08.2023VAXXAS AWARDED US$3.67 MILLION (AU$5.4 MILLION) FROM GLOBAL CHARITABLE FOUNDATION, WELLCOME, FOR HUMAN CLINICAL STUDY OF TYPHOID VACCINATION USING NEEDLE-FREE VACCINE PATCHCambridge, Mass., USA, and Brisbane, Queensland, Australia – August 23, 2023 – Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that the global charitable foundation, Wellcome, has...
29.04.2022OneVentures is growing its healthcare and biotech portfolio, with a focus on women-led startupsPrincipal Jeannie Joughin, Head of Marketing and Communications Carolyn Mller, and Investment Director Justine Carzino. Image: supplied. Australian VC OneVentures has bolstered its women-led leadership team ahead of plans to grow its funds ...
09.02.2022Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric PatientsGroundbreaking New Clinical Trial Data Published in The Lancet Child & Adolescent Health Data shows that 51% of participants achieved sustained unresponsiveness (clinical remission) to peanut after 18 months of treatment Prota Therapeut...
16.11.2021Global e-bike innovator Zoomo raises $60M to lead commercial e-bike industryThe equity raise was led by climate-action focused Australian VC Grok Ventures and positions Zoomo as the leader in the provision of e-bikes for delivery use Skip Capital and ArcTern Ventures also join the Series B funding round The round i...
15.11.2021Global e-bike innovator Zoomo raises $60M to lead commercial e-bike industryThe equity raise was led by climate-action focused Australian VC Grok Ventures and positions Zoomo as the leader in the provision of e-bikes for delivery use Skip Capital and ArcTern Ventures also join the Series B funding round The round i...
02.03.2021Australian startup Employment Hero secures AUD 45 million in Series D fundingSyndey-based human resource platform Employment Hero announced early in March 2021 that it had raised AUD 45 million in its Series D funding round. The round was led by SEEK, along with participation from existing investors Airtree Ventures...
28.01.2021Cloud data analytics service Phocas raises $34 million to grow AI, global footprintPhocas Software‘s cloud data analytics tools might be best known in Australia, where they’re used by Thermo Fisher Scientific, Fiskars Royal Doulton, and Burson Automotive to streamline employee access to key financial data, but the company...
28.01.2021Cloud data analytics service Phocas raises $34 million to grow AI, global footprintWe are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Phocas Software‘s cloud data analytics tools migh...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In